靶向设计通用流感疫苗中的 B 细胞反应。
Targeting B cell responses in universal influenza vaccine design.
机构信息
Committee on Immunology, The University of Chicago, Chicago, IL, USA.
出版信息
Trends Immunol. 2011 Nov;32(11):524-31. doi: 10.1016/j.it.2011.08.007. Epub 2011 Sep 21.
Abstract
Since its first administration in the 1940s, the influenza vaccine has provided tremendous relief against influenza infections. However, time has revealed the ultimate limit of the vaccine and the call for its reinvention has now come, just as we are beginning to appreciate the antibody immune responses vital in preventing infections. New strategies to design the influenza vaccine rely on selectively inducing broadly neutralizing antibodies that are specific for highly conserved viral epitopes. Such approaches take us away from the limited range of protection provided by current seasonal influenza vaccines and towards a future with a pan-influenza vaccine capable of providing universal strain coverage.
摘要
自 20 世纪 40 年代首次使用以来，流感疫苗在防治流感感染方面发挥了巨大作用。然而，时间已经揭示了疫苗的最终局限性，现在人们呼吁对其进行重新设计，就像我们开始认识到预防感染至关重要的抗体免疫反应一样。设计流感疫苗的新策略依赖于选择性诱导针对高度保守病毒表位的广泛中和抗体。这些方法使我们摆脱了当前季节性流感疫苗提供的有限保护范围，走向了能够提供通用菌株覆盖的泛流感疫苗的未来。
相似文献
1
Targeting B cell responses in universal influenza vaccine design.靶向设计通用流感疫苗中的 B 细胞反应。
Trends Immunol. 2011 Nov;32(11):524-31. doi: 10.1016/j.it.2011.08.007. Epub 2011 Sep 21.
2
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?头部、茎部以及其他一切：抗体如何根除作为人类疾病的流感？
Curr Opin Immunol. 2016 Oct;42:48-55. doi: 10.1016/j.coi.2016.05.012. Epub 2016 Jun 3.
3
Influenza vaccination strategies targeting the hemagglutinin stem region.针对血凝素茎区域的流感疫苗接种策略。
Immunol Rev. 2020 Jul;296(1):132-141. doi: 10.1111/imr.12887. Epub 2020 Jun 16.
4
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem.是否有可能开发出“通用”流感病毒疫苗？针对血凝素茎的泛亚型流感 A 疫苗开发中 B 细胞生物学的免疫遗传学考虑。
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):a029413. doi: 10.1101/cshperspect.a029413.
5
Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies.广谱反应性流感抗体不受高亲和力抗体与生发中心竞争的限制。
mBio. 2020 Nov 3;11(6):e01859-20. doi: 10.1128/mBio.01859-20.
6
B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.B 细胞对流感病毒的反应：针对终身威胁的短暂体液免疫。
Viruses. 2021 May 22;13(6):965. doi: 10.3390/v13060965.
7
A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.一种二价异源DNA病毒样颗粒初免-加强疫苗可引发针对1型和2型甲型流感病毒的广泛保护。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02052-16. Print 2017 May 1.
8
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.合成的Toll样受体4（TLR4）和TLR7配体作为流感病毒疫苗佐剂可诱导快速、持久且具有广泛保护性的反应。
J Virol. 2015 Mar;89(6):3221-35. doi: 10.1128/JVI.03337-14. Epub 2015 Jan 7.
9
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.评估BiondVax公司研发的通用流感疫苗（多聚体-001）作为单一疫苗或作为H5N1流感疫苗的引物的免疫原性和安全性：IIb期研究方案。
Medicine (Baltimore). 2017 Mar;96(11):e6339. doi: 10.1097/MD.0000000000006339.
10
Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.生成 DelNS1 流感病毒：优化活流感疫苗的策略。
mBio. 2019 Sep 17;10(5):e02180-19. doi: 10.1128/mBio.02180-19.
引用本文的文献
1
Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine.以血凝素鸡尾酒为靶点的策略作为一种潜在的通用流感疫苗。
Front Microbiol. 2022 Sep 29;13:1014122. doi: 10.3389/fmicb.2022.1014122. eCollection 2022.
2
Machine Learning to Quantify Humoral Selection in Human Lupus Tubulointerstitial Inflammation.机器学习定量分析人类狼疮肾小管间质性炎症中的体液选择。
Front Immunol. 2020 Nov 27;11:593177. doi: 10.3389/fimmu.2020.593177. eCollection 2020.
3
Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview.病毒感染治疗应用中中和抗体的最新进展：概述。
Immunol Res. 2020 Dec;68(6):325-339. doi: 10.1007/s12026-020-09159-z. Epub 2020 Nov 8.
4
Influenza vaccination strategies targeting the hemagglutinin stem region.针对血凝素茎区域的流感疫苗接种策略。
Immunol Rev. 2020 Jul;296(1):132-141. doi: 10.1111/imr.12887. Epub 2020 Jun 16.
5
Vaccination mitigates influenza-induced muscular declines in aged mice.接种疫苗可减轻老年小鼠流感引起的肌肉衰退。
Geroscience. 2020 Dec;42(6):1593-1608. doi: 10.1007/s11357-020-00206-z. Epub 2020 May 29.
6
ICAMs support B cell interactions with T follicular helper cells and promote clonal selection.细胞间黏附分子支持B细胞与滤泡辅助性T细胞的相互作用并促进克隆选择。
J Exp Med. 2017 Nov 6;214(11):3435-3448. doi: 10.1084/jem.20171129. Epub 2017 Sep 22.
7
Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation.低CD21表达定义了一群准备好进行浆细胞分化的生发中心新产生的细胞群体。
Sci Immunol. 2017 Jan 27;2(7). doi: 10.1126/sciimmunol.aai8153.
8
A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.表达嵌合H5血凝素的改良安卡拉痘苗病毒疫苗载体可减少恒河猴的病毒脱落。
PLoS One. 2017 Aug 3;12(8):e0181738. doi: 10.1371/journal.pone.0181738. eCollection 2017.
9
Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.衰老和巨细胞病毒对流感疫苗接种及感染免疫反应的影响
Front Immunol. 2017 Jul 17;8:784. doi: 10.3389/fimmu.2017.00784. eCollection 2017.
10
Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses.通过直接破坏病毒，来源于 vFLIP 的肽抑制高致病性禽流感（HPAI）病毒。
Sci Rep. 2017 Jul 7;7(1):4875. doi: 10.1038/s41598-017-04777-4.
本文引用的文献
1
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin.广谱中和人抗体，识别流感病毒血凝素的受体结合口袋。
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21. doi: 10.1073/pnas.1111497108. Epub 2011 Aug 8.
2
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.一种从浆细胞中筛选出的能够与甲型流感血凝素 1 型和 2 型结合的中和抗体。
Science. 2011 Aug 12;333(6044):850-6. doi: 10.1126/science.1205669. Epub 2011 Jul 28.
3
A highly conserved neutralizing epitope on group 2 influenza A viruses.群组 2 流感病毒上一个高度保守的中和表位。
Science. 2011 Aug 12;333(6044):843-50. doi: 10.1126/science.1204839. Epub 2011 Jul 7.
4
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.MF59 佐剂增强了对大流行性流感疫苗的抗体介导的免疫应答的多样性和亲和力。
Sci Transl Med. 2011 Jun 1;3(85):85ra48. doi: 10.1126/scitranslmed.3002336.
5
Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies.广泛存在异源广谱中和性抗甲型流感人抗体。
Clin Infect Dis. 2011 Apr 15;52(8):1003-9. doi: 10.1093/cid/cir121.
6
2009 H1N1 influenza pandemic: field and epidemiologic investigations in the United States at the start of the first pandemic of the 21st century.2009 年 H1N1 流感大流行：21 世纪首次大流行期间美国的现场和流行病学调查。
Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S1-3. doi: 10.1093/cid/ciq005.
7
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.广泛交叉反应性抗体主导了人类针对 2009 年大流行 H1N1 流感病毒感染的 B 细胞反应。
J Exp Med. 2011 Jan 17;208(1):181-93. doi: 10.1084/jem.20101352. Epub 2011 Jan 10.
8
Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus.通用抗体针对高度保守的流感融合肽进行交叉中和，可中和几种亚型的甲型流感病毒。
Biochem Biophys Res Commun. 2010 Dec 10;403(2):247-51. doi: 10.1016/j.bbrc.2010.11.030. Epub 2010 Nov 13.
9
Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.大流行 2009 H1N1 疫苗可预防 1918 年西班牙流感病毒。
Nat Commun. 2010 Jun 15;1(3):28. doi: 10.1038/ncomms1026.
10
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.接种流感病毒血凝素的合成肽可提供针对不同病毒亚型的保护。
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18979-84. doi: 10.1073/pnas.1013387107. Epub 2010 Oct 18.
Zotero 插件